COMPASS Pathways Investor Relations Material
Latest events
Q2 2025
COMPASS Pathways
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from COMPASS Pathways Plc
Access all reports
COMPASS Pathways Plc is a mental health care company developing psychedelic-based therapies for the treatment of mental health disorders. The company focuses on clinical research and development of psilocybin-assisted therapies for conditions such as treatment-resistant depression. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CMPS
Country
🇺🇸 United States